39868-71-8

Usage

Uses

Used in Pharmaceutical Industry:
1-bromo-4-cyclobutyl-benzene serves as an intermediate in organic synthesis, playing a crucial role in the production of various pharmaceuticals. Its unique structure allows for the creation of a wide range of medicinal compounds, contributing to the development of new drugs and therapies.
Used in Agrochemical Industry:
Similarly, in the agrochemical sector, 1-bromo-4-cyclobutyl-benzene is employed as an intermediate for synthesizing different agrochemicals. This includes the production of pesticides, herbicides, and other chemicals that are vital for agricultural applications, helping to ensure crop protection and increased yields.
It is important to handle 1-bromo-4-cyclobutyl-benzene with care, as it is a flammable liquid and can cause skin and eye irritation upon contact. Proper safety measures should be taken during its use and storage to minimize potential hazards.

Upstream product

• 19936-14-2 1-(4-bromophenyl)cyclobutan-1-ol 

Downstream Products

• 1276635-04-1 1-(4-cyclobutylphenyl)pentan-1-one 
• 24993-85-9 p-vinylvalerophenone 
• 10537-63-0 1-(4-vinylphenyl)ethanone 
• 6921-50-2 1-(4-cyclobutylphenyl)ethenone 
• 433692-25-2 (4-cyclobutylphenyl)(phenyl)methanone 
• 1276635-19-8 C₃₄H₃₄O₂ 
• 19936-14-2 1-(4-bromophenyl)cyclobutan-1-ol 

Relevant academic research and scientific papers

Liquid Crystal compound containing cyclobutyl group and difluoromethyleneoxy linking group, and preparation method and use thereof

A liquid crystal compound containing cyclobutyl and a linking group difluoromethyleneoxy, and a preparation method and use thereof are disclosed. The compound is as shown in Formula I. The liquid crystal compound containing cyclobutyl as a terminal group

SUBSTITUTED 2,4,5,6-TETRAHYDROPYRROLO[3,4-C] PYRAZOLE AND 4,5,6,7-TETRAHYDRO-2H-PYRAZOLO [4,3-C] PYRIDINE COMPOUNDS AS GLYT1 INHIBITORS

The invention provides a chemical entity of Formula (I), wherein R1, R2, R3, R4, R5 and X have any of the values described herein, and compositions comprising such chemical entities; methods of making them; and their use in a wide range of methods, including metabolic and reaction kinetic studies; detection and imaging techniques; radioactive treatments; modulating and treating disorders mediated by GlyT1 activity; treating neurological disorders, CNS disorders, dementia, neurodegenerative diseases, and trauma-dependent losses of function; treating stroke, including cognitive and motor deficits during stroke rehabilitation; facilitating neuroprotection and neurorecovery; enhancing the efficiency of cognitive and motor training, including animal skill training; and treating other disorders, including pain and alcohol-dependence.

Heteroaryl and benzyl amide compounds

Compounds of formula I wherein R1, R2, R4, R5, A, B, D and n are as defined, and pharmaceutically acceptable salts thereof, processes for their preparation, their use as pharmaceuticals and pharmaceutical compositions comprising them.